Analysts Offer Insights on Healthcare Companies: Bioventus (BVS), Stryker (SYK) and Codexis (CDXS)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioventus (BVS – Research Report), Stryker (SYK – Research Report) and Codexis (CDXS – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bioventus (BVS)
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Bioventus today. The company’s shares closed last Thursday at $9.21.
According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of
Currently, the analyst consensus on Bioventus is a Strong Buy with an average price target of $14.00, which is a 55.6% upside from current levels. In a report released today, TipRanks – Google also upgraded the stock to Buy with a $9.50 price target.
See Insiders’ Hot Stocks on TipRanks >>
Stryker (SYK)
In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Stryker. The company’s shares closed last Thursday at $372.63.
According to TipRanks.com, Steed is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stryker with a $430.06 average price target, which is a 14.0% upside from current levels. In a report issued on February 20, William Blair also initiated coverage with a Buy rating on the stock.
Codexis (CDXS)
Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Codexis today. The company’s shares closed last Thursday at $1.25.
According to TipRanks.com, Hewitt has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Codexis.
